SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
NC Global Advantage Forum
Event | 11. 10. 2022
Karent LeVert will be speaking at the NC Global Advantage Forum on the impact of climate change on agriculture and how North Carolina's growing AgTech prowess can make a global impact.
